Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases

BACKGROUND: Immunosuppressed patients are particularly vulnerable to severe infection from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), risking prolonged viremia and symptom duration. In this study we describe clinical and virological treatment outcomes in a heterogeneous group...

Descripción completa

Detalles Bibliográficos
Autores principales: Ljungquist, Oskar, Lundgren, Maria, Iliachenko, Elena, Månsson, Fredrik, Böttiger, Blenda, Landin-Olsson, Mona, Wikén, Christian, Rosendal, Ebba, Överby, Anna K., Wigren, Byström J., Forsell, Mattias N. E., Kjeldsen-Kragh, Jens, Rasmussen, Magnus, Kahn, Fredrik, Holm, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726003/
https://www.ncbi.nlm.nih.gov/pubmed/34878955
http://dx.doi.org/10.1080/23744235.2021.2013528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726003/
https://www.ncbi.nlm.nih.gov/pubmed/34878955
http://dx.doi.org/10.1080/23744235.2021.2013528

Ejemplares similares